SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (20185)3/30/1999 10:36:00 PM
From: blankmind  Read Replies (1) of 23519
 
In the beginning of this year, I became a buyer & holder of MSFT.

- Bought it at $75; MSFT ran up to 88; then down to 70; and now it's 91.

- And the trend is up.

- Yet with VVUS, despite all its triumphs and a female SD cream, should be $100+++ & it's under $4.

- Don't get me wrong. If VVUS came out with a pill that was attributed to 200+ deaths, then yes, it should be under $4. But now with Alibra & everything else....Ahhhhhhhhhhhhhhhhhhh!!!!!!!!!!!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News